Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families

Abstract

Germline mutations in succinate dehydrogenase subunits B, C and D (SDHB, SDHC and SDHD), genes encoding subunits of mitochondrial complex II, cause hereditary paragangliomas and phaeochromocytomas. In SDHB (1p36)- and SDHC (1q21)-linked families, disease inheritance is autosomal dominant. In SDHD (11q23)-linked families, the disease phenotype is expressed only upon paternal transmission of the mutation, consistent with maternal imprinting. However, SDHD shows biallelic expression in brain, kidney and lymphoid tissues (Baysal et al., 2000). Moreover, consistent loss of the wild-type (wt) maternal allele in SDHD-linked tumours suggests expression of the maternal SDHD allele in normal paraganglia. Here we demonstrate exclusive loss of the entire maternal chromosome 11 in SDHD-linked paragangliomas and phaeochromocytomas, suggesting that combined loss of the wt SDHD allele and maternal 11p region is essential for tumorigenesis. We hypothesize that this is driven by selective loss of one or more imprinted genes in the 11p15 region. In paternally, but not in maternally derived SDHD mutation carriers, this can be achieved by a single event, that is, non-disjunctional loss of the maternal chromosome 11. Thus, the exclusive paternal transmission of the disease can be explained by a somatic genetic mechanism targeting both the SDHD gene on 11q23 and a paternally imprinted gene on 11p15.5, rather than imprinting of SDHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Abeln EC, Corver WE, Kuipers-Dijkshoorn NJ, Fleuren GJ and Cornelisse CJ . (1994). Br.J.Cancer, 70, 255–262.

  • Astrom K, Cohen JE, Willett-Brozick JE, Aston CE and Baysal BE . (2003). Hum.Genet., 113, 228–237.

  • Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C and Maher ER . (2001). Am.J.Hum.Genet., 69, 49–54.

  • Balmain A, Gray J and Ponder B . (2003). Nat.Genet., 33 (Suppl), 238–244.

  • Baysal BE, Farr JE, Rubinstein WS, Galus RA, Johnson KA, Aston CE, Myers EN, Johnson JT, Carrau R, Kirkpatrick SJ, Myssiorek D, Singh D, Saha S, Gollin SM, Evans GA, James MR and Richard III CW . (1997). Am.J.Hum.Genet., 60, 121–132.

  • Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der MA, Taschner PE, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P and Devlin B . (2000). Science, 287, 848–851.

  • Beerman H, Kluin PM, Hermans J, van de Velde CJ and Cornelisse CJ . (1990). Int.J.Cancer, 45, 34–39.

  • Biggs PJ, Vogel H, Sage M, Martin LA, Donehower LA and Bradley A . (2003). Oncogene, 22, 3288–3296.

  • Burns JL and Hassan AB . (2001). Development, 128, 3819–3830.

  • Cooke HJ and Hindley J . (1979). Nucleic Acids Res., 6, 3177–3197.

  • Dannenberg H, de Krijger RR, Zhao J, Speel EJ, Saremaslani P, Dinjens WN, Mooi WJ, Roth J, Heitz PU and Komminoth P . (2001). Am.J.Pathol., 158, 1937–1942.

  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . (1997). Cell, 91, 231–241.

  • Devilee P, Cleton-Jansen AM and Cornelisse CJ . (2001). Trends Genet., 17, 569–573.

  • Devilee P, van Schothorst EM, Bardoel AF, Bonsing B, Kuipers-Dijkshoorn N, James MR, Fleuren G, van der Mey AG and Cornelisse CJ . (1994). Genes Chromosomes Cancer, 11, 71–78.

  • Douwes Dekker PB, Kuipers-Dijkshoorn N, Hogendoorn PC, van der Mey AG and Cornelisse CJ . (2003). Hum.Pathol., 34, 690–698.

  • Edstrom E, Mahlamaki E, Nord B, Kjellman M, Karhu R, Hoog A, Goncharov N, Teh BT, Backdahl M and Larsson C . (2000). Am.J.Pathol., 156, 651–659.

  • Eng C, Kiuru M, Fernandez MJ and Aaltonen LA . (2003). Nat.Rev.Cancer, 3, 193–202.

  • Fournet JC, Mayaud C, de Lonlay P, Gross-Morand MS, Verkarre V, Castanet M, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM and Junien C . (2001). Am.J.Pathol., 158, 2177–2184.

  • Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP and Le Bouc Y . (1997). J.Clin.Endocrinol.Metab., 82, 2559–2565.

  • Haralambieva E, Kleiverda K, Mason DY, Schuuring E and Kluin PM . (2002). J.Pathol., 198, 163–170.

  • Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E and Kluin PM . (2002). Genes Chromosomes Cancer, 35, 38–48.

  • Li YM, Franklin G, Cui HM, Svensson K, He XB, Adam G, Ohlsson R and Pfeifer S . (1998). J.Biol.Chem., 273, 28247–28252.

  • Lui WO, Chen J, Glasker S, Bender BU, Madura C, Khoo SK, Kort E, Larsson C, Neumann HP and Teh BT . (2002). Oncogene, 21, 1117–1122.

  • Mariman EC, van Beersum SE, Cremers CW, van Baars FM and Ropers HH . (1993). Hum.Genet., 91, 357–361.

  • Niemann S and Muller U . (2000). Nat.Genet., 26, 268–270.

  • Runge S, Nielsen FC, Nielsen J, Lykke-Andersen J, Wewer UM and Christiansen J . (2000). J.Biol.Chem., 275, 29562–29569.

  • Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB and Friend SH . (2003). Nature, 422, 297–302.

  • Stewart CE and Rotwein P . (1996). Physiol. Rev., 76, 1005–1026.

  • Tycko B . (2000). J.Clin.Invest., 105, 401–407.

  • van der Mey AG, Cornelisse CJ, Hermans J, Terpstra JL, Schmidt PH and Fleuren GJ . (1991). Br.J.Cancer, 63, 298–302.

  • van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH and van de Kamp JJ . (1989). Lancet, 2, 1291–1294.

  • van Schothorst EM, Beekman M, Torremans P, Kuipers-Dijkshoorn NJ, Wessels HW, Bardoel AF, van der Mey AG, van der Vijver MJ, van Ommen GJ, Devilee P and Cornelisse CJ . (1998a). Hum.Pathol., 29, 1045–1049.

  • van Schothorst EM, Jansen JC, Grooters E, Prins DE, Wiersinga JJ, van der Mey AG, van Ommen GJ, Devilee P and Cornelisse CJ . (1998b). Am.J.Hum.Genet., 63, 468–473.

  • Waye JS, Creeper LA and Willard HF . (1987). Chromosoma, 95, 182–188.

  • Waziri M, Patil SR, Hanson JW and Bartley JA . (1983). J.Pediatr., 102, 873–876.

  • Weksberg R and Squire JA . (1996). Med.Pediatr.Oncol., 27, 462–469.

Download references

Acknowledgements

We thank CJ Haven for help with the FISH experiments and NJ Kuipers-Dijkshoorn for technical assistance. We acknowledge T van Wezel and M Lombaerts for helpful comments on the manuscript. This research was supported by a grant from the JANIVO foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cees J Cornelisse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hensen, E., Jordanova, E., van Minderhout, I. et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23, 4076–4083 (2004). https://doi.org/10.1038/sj.onc.1207591

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207591

Keywords

This article is cited by

Search

Quick links